Author(s): K. Saranya, V. Manivasagan, N.G. Ramesh Babu, D. Pradeep, S. Pandidurai

Email(s): ksaranya31@gmail.com

DOI: Not Available

Address: K. Saranya*, V. Manivasagan, N.G. Ramesh Babu, D. Pradeep, S. Pandidurai
Department of Biotechnology, Adhiyamaan College of Engineering, Hosur.
*Corresponding Author

Published In:   Volume - 4,      Issue - 4,     Year - 2013


ABSTRACT:
Blood substitutes are currently undergoing preliminary clinical trials to determine their safety. Two distinctly different classes of oxygen carriers are being developed, each capable of transporting and delivering oxygen to peripheral tissues. The delivery of oxygen by these two methodologies may have both benefits and risks which are unique to its class. Early clinical trials have been promising. However, effective use of these blood substitutes may involve using them in conjunction with other techniques such as normovolemic hemodilution to effectively reduce or eliminate the need for transfusions in certain instances. However, this first generation of clinically safe blood substitutes will not replace allogeneic blood transfusions as a means of treating many types of anemia.


Cite this article:
K. Saranya, V. Manivasagan, N.G. Ramesh Babu, D. Pradeep, S. Pandidurai. Emerging Trends in Artificial Blood. Research J. Engineering and Tech. 4(4): Oct.-Dec., 2013 page 199-207.


Recomonded Articles:

Author(s): K. Saranya, V. Manivasagan, N.G. Ramesh Babu, D. Pradeep, S. Pandidurai

DOI:         Access: Open Access Read More

Research Journal of Engineering and Technology (RJET) is an international, peer-reviewed, research journal aiming at promoting and publishing original high quality research in all disciplines of engineering sciences and technology....... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2321-581X 


Recent Articles




Tags